A.R.T. Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

A.R.T. Advisors’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,542	Closed	-$127K	–	1976
2018 Q1	$127K	Buy	+12,542	New	+$105K	0.01%	1333
2014 Q4	–	Sell	-11,092	Closed	-$65K	–	1801
2014 Q3	$65K	Buy	+11,092	New	+$67.7K	﹤0.01%	1231
2014 Q2	–	Sell	-15,325	Closed	-$110K	–	1664
2014 Q1	$110K	Sell	15,325 -6,033	-28%	-$41.7K	0.01%	1230
2013 Q4	$141K	Sell	21,358 -1,100	-5%	-$7.49K	0.01%	1162
2013 Q3	$163K	Buy	+22,458	New	+$151K	0.01%	1171

Other funds holding JNP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

A.R.T. Advisors's JNP Position: Q2 2018 in Review

A.R.T. Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2018, closing a stake of 12,542 shares — an estimated $127K sold.

A.R.T. Advisors first reported a position in JNP in Q3 2013 and held it in 5 quarters. The position peaked at $163K in Q3 2013. 48 funds tracked by Wall St. Rank hold JNP as of Q2 2018.

A.R.T. Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
A.R.T. Advisors sold 12,542 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $127K.
A.R.T. Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
A.R.T. Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $163K in Q3 2013.
48 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.